EDGAR Filing Documents for 0001193125-06-032360

Form 8-K - Current report:

SEC Accession No. 0001193125-06-032360

Filing Date

2006-02-15

Accepted

2006-02-15 11:37:50

Documents

Period of Report

2006-02-14

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	34366
2	FORM OF 7% CONVERTIBLE DEBENTURE DATED FEBRUARY 14, 2006	dex41.htm	EX-4.1	136638
3	FORM OF COMMON STOCK PURCHASE WARRANT	dex42.htm	EX-4.2	79015
4	FORM OF REGISTRATION RIGHTS AGREEMENT	dex43.htm	EX-4.3	110799
5	SECURITIES PURCHASE AGREEMENT	dex101.htm	EX-10.1	182564
6	PRESS RELEASE	dex991.htm	EX-99.1	8658
	Complete submission text file	0001193125-06-032360.txt		553783

Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459

Business Address 189 WELLS ST STE 200 NEWTON MA 02459 6175590033

PRO PHARMACEUTICALS INC (Filer) CIK: 0001133416 (see all company filings)